This report describes retinitis pigmentosa 4 (RP4), which is a subtype of retinitis pigmentosa. The human gene implicated in this disease is the rhodopsin gene RHO. This form of retinitis pigmentosa is typically inherited as an autosomal dominant. In humans, the RHO gene is also associated with several other retinal diseases (MIM:180380). Both humans and flies have multiple rhodopsin genes. Many of the orthologous human genes are associated with retinal disease; see the report 'retinal disease, rhodopsin-related' (FBhh0000219).
Dmel\ninaE and Dmel\Rh6 are the best orthologous hits to human RHO, however, each of these two fly genes also has moderate-scoring hits to other rhodopsin genes in humans. Dmel\ninaE has been extensively characterized; classical amorphic and hypomorphic alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated for this gene. For Dmel\Rh6, a more limited number of classical mutations and RNAi-targeting constructs are available.
The human RHO gene has not been introduced into flies.
Variant(s) implicated in human disease tested (as analogous mutation in fly gene): P37H in the fly ninaE gene (corresponds to P23H in the human RHO gene).
In animals carrying null mutations of ninaE, the adult compound eye does not develop normally. There are defects in the rhabdomeres of photoreceptor cells R1-R6; progressive retinal degeneration is observed. Expression of a transgenic ninaE allele analogous to a known RP4 mutation in the human RHO gene results in progressive retinal degeneration in adults. Many genetic and physical interactions of Dmel\ninaE have been described; see below and in the gene report for ninaE.
[updated Jun. 2017 by FlyBase; FBrf0222196]
Retinitis pigmentosa (RP) refers to a heterogeneous group of inherited ocular diseases that result in a progressive retinal degeneration affecting 1 in 3,000 to 5,000 people (Veltel et al., 2008; pubmed:18376416). Symptoms include night blindness, the development of tunnel vision, and slowly progressive decreased central vision starting at approximately 20 years of age. [from MIM:268000; 2016.03.07]
The rate and extent of disease progression vary markedly among RP patients, in some cases, even within the same family. [from MIM:600059; 2020.08.04]
[RETINITIS PIGMENTOSA 4; RP4](https://omim.org/entry/613731)
[RHODOPSIN; RHO](https://omim.org/entry/180380)
See general description, above. In some pedigrees, retinitis pigmentosa 4 is associated with early, rapidly progressing, and severe retinal dysfunction. [from MIM:613731; 2016.03.09]
In a study of 270 families with histories of autosomal dominant retinitis pigmentosa, mutations in the RHO gene were found in 31% (Daiger et al., 2014; pubmed:25304133).
Retinitis pigmentosa 4 (RP4) is caused by heterozygous, and rarely by homozygous, mutation in the rhodopsin (RHO) gene. [from MIM:613731; 2016.03.09]
Rhodopsin is the visual pigment of photoreceptors with rod-shaped outer segments (retinal rods). Rhodopsin mediates vision in dim light and absorbs maximally at 495 nm (summary by Nathans et al., 1986; pubmed:3485310). [from MIM:180380; 2016.03.09]
Ortholog of human genes OPN4 (reciprocal best hit); lower-scoring ortholog of OPN1LW, RHO and multiple other human opsin genes (multiple Drosophila to multiple human). Dmel\ninaE shares 27-34% identity and 46-51% similarity with these human genes.